Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-23-011777

General Counsel and Secretary gave up 1,950 shares (to pay taxes)

  • General Counsel and Secretary acquired 3,825 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2023-02-18 Option exercise +3,825 54,016 D
KASINGER JAMES R. General Counsel and Secretary 2023-02-21 Shares withheld for taxes −1,950 $48.26 $94,107 52,066 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2023-02-18 Option exercise · Restricted Stock Units −3,825 11,475 D
Loading xslF345X03/doc4.xml…